Ivermectin/ Permethrin for Scabies
Scabies
About this trial
This is an interventional treatment trial for Scabies
Eligibility Criteria
Inclusion Criteria: Male or female Age 6 years or above Body weight 15kg or above Clinical establishment of diagnosed scabies Exclusion Criteria: Pregnant or breastfeeding woman Scabies with secondary infection Scabies with eczematization History of receiving scabies treatment in the last four weeks History of drug hypersensitivity
Sites / Locations
- Ciumbuleuit Public Health Centre
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Oral ivermectin 3 dosages and placebo
Oral ivermectin 2 dosages and placebo
Permethrin 5% cream 2 applications and placebo
Twenty patients will be administered randomly oral ivermectin 200µg/kg BW on days 1, 2, and 8 and also placebo cream on days 1 and 8 Placebo cream: Cream base
Twenty patients will be administered randomly oral ivermectin 200µg/kg BW on days 1 and 8 and also oral placebo on day 2, placebo cream on days 1 and 8 Placebo cream: Cream base
Twenty patients will be administered randomly permethrin 5% cream on days 1 and 8 and also oral placebo on days 1, 2, and 8 Placebo: vitamin B complex